Form 4: Director Celeste Fralick Converts Restricted Stock Units into Aspira Women's Health Common Stock
SEC Form 4 Filing
Celeste Fralick, a director of Aspira Women's Health Inc., converted 5,000 restricted stock units (RSUs) into common stock on September 30, 2024.
Summary
- On September 30, 2024, Celeste Fralick, a director of Aspira Women's Health Inc., converted 5,000 restricted stock units (RSUs) into common stock.
- The RSUs were part of a grant of 20,000 RSUs awarded on August 22, 2024, with 5,000 vesting on September 30, 2024.
- Following the transaction, Fralick directly owns 45,665 shares of Aspira Women's Health Inc. common stock and 15,000 RSUs.
Sentiment
Score: 5
Explanation: The document is a routine SEC Form 4 filing, indicating a standard transaction of RSU conversion. It doesn't inherently convey positive or negative sentiment.
Key Dates
| Date | Description |
|---|---|
| 08/22/2024 | Reporting person was granted 20,000 RSUs. |
| 08/26/2024 | Previous Form 4 filed with the SEC reporting the RSU grant. |
| 09/30/2024 | 5,000 RSUs vested and were converted into common stock. |
| 10/02/2024 | Date of signature on the Form 4. |
Keywords
Aspira Women's Health, Director, Celeste Fralick, RSUs, Common Stock, Form 4, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.